Clinical trials are underway to study GLP-1 medications for things like heart failure, smoking cessation, alcohol use disorder, nonalcoholic fatty liver disease, and even neurodegenerative conditions like Alzheimers
Understanding Semaglutide Semaglutide is a prescription medication originally developed to treat type 2 diabetes it works by mimicking a hormone in the body called glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels
Semaglutide GLP-1 activates GLP-1 receptors in the brain, which leads to a decrease in the activity of the hunger center
Liraglutide and Semaglutide GLP-1 are medications that mimic the effects of a hormone called glucagon-like peptide-1 (GLP-1), aiding in the release of insulin and helping to lower blood sugar levels
The key difference is that Tirzepatide targets two hormones (GLP-1 and GIP), while Semaglutide targets only GLP-1
In the STEP obesity trials, participants lost 1015% of body weight and showed sustained improvements in blood pressure, triglycerides, and inflammatory markers